Menu Search
Equities

Cigna Group

CI:DEU

Cigna Group

Actions
  • Price (EUR)314.85
  • Today's Change8.15 / 2.66%
  • Shares traded25.00
  • 1 Year change+20.22%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.

  • Revenue in USD (TTM)232.59bn
  • Net income in USD3.04bn
  • Incorporated2018
  • Employees72.50k
  • Location
    Cigna Group900 Cottage Grove RoadBLOOMFIELD 06002-2920United StatesUSA
  • Phone+1 (860) 226-6000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.thecignagroup.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		CI:NYQ since
announced		Transaction
value
Humana IncPrior rumour discounted29 Nov 202329 Nov 2023Prior rumour discounted14.11%--
Data delayed at least 15 minutes, as of Nov 22 2024 17:34 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.